http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1878312_PMID35073486

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482058457_AID1878312_PMID35073486_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482075357_AID1878312_PMID35073486_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482071823_AID1878312_PMID35073486_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482048409_AID1878312_PMID35073486_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482083382_AID1878312_PMID35073486_VALUE9
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482082206_AID1878312_PMID35073486_VALUE8
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482047406_AID1878312_PMID35073486_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID104234145_AID1878312_PMID35073486_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID482046598_AID1878312_PMID35073486_VALUE2
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08183
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Inhibition of P-gp mediated doxorubicin resistance in human SW620/AD300 cells overexpressing P-gp in presence of doxorubicin measured after 52 hrs by MTT assay
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482046598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482047406
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482058457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482071823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482082206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID104234145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482048409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482075357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482083382
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1878312

Total number of triples: 23.